0.00Open0.01Pre Close0 Volume218 Open Interest825.00Strike Price0.00Turnover1380.41%IV7.83%PremiumJan 3, 2025Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0023Delta0.0005Gamma76510.00Leverage Ratio-64.8502Theta0.0000Rho176.40Eff Leverage0.0001Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet